Phase 1 study of PSCA-targeted chimeric antigen receptor (CAR) T cell therapy for metastatic castration-resistant prostate cancer (mCRPC).

被引：16

作者：

Dorff, Tanya B.

Blanchard, Suzette

Martirosyan, Hripsime

Adkins, Lauren

Dhapola, Gaurav

Moriarty, Aidan

Wagner, Jamie R.

Chaudhry, Ammar

D'Apuzzo, Massimo

Kuhn, Peter

Forman, Stephen J.

Priceman, Saul

机构：

[1] City Hope Comprehens Canc Ctr, Duarte, CA USA

[2] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[3] City Hope Natl Med Ctr, Duarte, CA USA

[4] USC MIchelson Ctr Convergent Biosci, Los Angeles, CA USA

[5] Univ Southern Calif, Los Angeles, CA 90007 USA

来源：

关键词：

D O I：

10.1200/JCO.2022.40.6_suppl.091

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3